In vitro metabolism of etoposide (VP-16-213) by liver microsomes and irreversible binding of reactive intermediates to microsomal proteins.
about
Novel antitumor agents from higher plants.A review on plant-derived natural products and their analogs with anti-tumor activity.A phase I study on the reversal of multidrug resistance (MDR) in vivo: nifedipine plus etoposideButhionine sulphoximine-mediated sensitisation of etoposide-resistant human breast cancer MCF7 cells overexpressing the multidrug resistance-associated protein involves increased drug accumulationOral treatment with etoposide in small cell lung cancer - dilemmas and solutions.Role of nitric oxide in the chemistry and anticancer activity of etoposide (VP-16,213).Nitric oxide inhibits topoisomerase II activity and induces resistance to topoisomerase II-poisons in human tumor cells.Effect of nitric oxide on the anticancer activity of the topoisomerase-active drugs etoposide and adriamycin in human melanoma cells.Interaction of anticancer drugs with hepatic monooxygenase enzymes.Glutathione-mediated antioxidant response and aerobic metabolism: two crucial factors involved in determining the multi-drug resistance of high-risk neuroblastoma.Biodegradability of the anticancer drug etoposide and identification of the transformation products.Simultaneous determination of etoposide and its catechol metabolite in the plasma of pediatric patients by liquid chromatography/tandem mass spectrometry.Cytochrome P-450- and peroxidase-dependent activation of procarbazine and iproniazid in mammalian cells.Tyrosinase-induced free radical formation from VP-16,213: relationship to cytotoxicity.Iron-dependent hydroxyl radical formation and DNA damage from a novel metabolite of the clinically active antitumor drug VP-16.Synergistic enhancement of topotecan-induced cell death by ascorbic acid in human breast MCF-7 tumor cells.
P2860
Q33771941-F97DC249-05B5-43E8-8A97-831C95CFDE9AQ34511478-985777C1-11D2-4687-9BD4-FF06CEF35F40Q35993988-4C52368E-D818-4567-9E34-D0AC7AE110CFQ36080710-BBBDA8A2-2574-4BAE-B707-9C92321F7A5CQ36613874-D88D44A2-F786-4B46-AD9E-EF1BB43AE55FQ36971716-00E9D687-04D3-4BC6-84AA-5C5D7987182FQ37008894-AC7E24D8-418E-4D9A-A9E7-936FB9C92CA0Q37331797-2A851363-6BCA-4880-9B0B-88E5A893896EQ38709449-3EE7392E-13E3-41EF-B021-3FEDFDE3C4A9Q38743262-98A8AB3E-70C6-4F56-B685-27E6E9710692Q39742523-3BC0DA1A-D7EF-42DA-817C-F56D0581927EQ40694954-1E5DB66A-BBB5-4C38-AB59-132C443E1CF9Q41708596-6523F70C-E2F0-4E5C-8E5F-551ACD22AE92Q44472495-E4D54871-5904-45DE-BB28-49ED912C12D9Q45052309-F9C0A668-F958-47B3-A4C1-D30E439CACD8Q46273019-3765B082-F77A-4F36-9EDC-EA78D889EE83
P2860
In vitro metabolism of etoposide (VP-16-213) by liver microsomes and irreversible binding of reactive intermediates to microsomal proteins.
description
1987 nî lūn-bûn
@nan
1987年の論文
@ja
1987年学术文章
@wuu
1987年学术文章
@zh-cn
1987年学术文章
@zh-hans
1987年学术文章
@zh-my
1987年学术文章
@zh-sg
1987年學術文章
@yue
1987年學術文章
@zh
1987年學術文章
@zh-hant
name
In vitro metabolism of etoposi ...... diates to microsomal proteins.
@en
In vitro metabolism of etoposide
@nl
type
label
In vitro metabolism of etoposi ...... diates to microsomal proteins.
@en
In vitro metabolism of etoposide
@nl
prefLabel
In vitro metabolism of etoposi ...... diates to microsomal proteins.
@en
In vitro metabolism of etoposide
@nl
P2093
P1476
In vitro metabolism of etoposi ...... diates to microsomal proteins.
@en
P2093
P304
P356
10.1016/0006-2952(87)90362-5
P407
P577
1987-02-01T00:00:00Z